drugset / Trial / NCT01439347
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
RandomizedParallel-groupOpen-labelTreatment
Summary
A phase 3 study in the treatment of subjects \>or= 60 years old with newly diagnosed acute lymphoblastic leukemia (ALL).
Timeline
- Start
- 2012-03
- Primary completion
- 2015-11
- Completion
- 2015-11
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vincristine | Small molecule | 1.4 mg/m2 | Intravenous |
| Subject | Vincristine | Small molecule | 2.25 mg/m2 | Intravenous |